Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cholangiocarcinoma Treatment with Radiofrequency Ablation or Photodynamic Therapy: a Randomized Controlled Trial

NCT05551299 is registered in ClinicalTrials.gov with University of Leipzig as lead sponsor.

NCT NCT05551299
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05551299 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cholangiocarcinoma Treatment with Radiofrequency Ablation or Photodynamic Therapy: a Randomized Controlled Trial
Lead sponsor
University of Leipzig
Phase
Phase 4
Overall status
Recruiting
Start date
February 10, 2023
Completion date
April 30, 2028
Enrollment
258 (estimated)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

hilar cholangiocarcinoma